Pages that link to "Q57579999"
Jump to navigation
Jump to search
The following pages link to Phase 2 randomized trial of primary endocrine therapy versus chemotherapy in postmenopausal patients with estrogen receptor-positive breast cancer (Q57579999):
Displaying 50 items.
- Neoadjuvant endocrine therapy in breast cancer: current role and future perspectives (Q26773012) (← links)
- Optimal management of breast cancer in the elderly patient: current perspectives (Q27690879) (← links)
- Neoadjuvant therapy in the treatment of breast cancer (Q27694514) (← links)
- A polymorphism at the 3'-UTR region of the aromatase gene defines a subgroup of postmenopausal breast cancer patients with poor response to neoadjuvant letrozole (Q33694817) (← links)
- A nation-wide multicenter 10-year (1999-2008) retrospective clinical study of endocrine therapy for Chinese females with breast cancer (Q33921197) (← links)
- Optimizing the use of neoadjuvant endocrine therapy (Q33925038) (← links)
- Neoadjuvant Endocrine Therapy in Breast Cancer (Q34096272) (← links)
- The nonsteroidal anti-inflammatory drug tolfenamic acid inhibits BT474 and SKBR3 breast cancer cell and tumor growth by repressing erbB2 expression (Q34127212) (← links)
- Neoadjuvant endocrine therapy in primary breast cancer: indications and use as a research tool (Q34253719) (← links)
- Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-bas (Q35023441) (← links)
- Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study (Q35108707) (← links)
- Phase II randomized trial of neoadjuvant metformin plus letrozole versus placebo plus letrozole for estrogen receptor positive postmenopausal breast cancer (METEOR) (Q35115517) (← links)
- Review of breast conservation therapy: then and now (Q35433289) (← links)
- Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone receptor-positive breast cancer (Q35671180) (← links)
- Luminal-B breast cancer and novel therapeutic targets (Q35889534) (← links)
- Invasive papillary carcinoma treated with neoadjuvant endocrine therapy in which pathological complete response was achieved (Q35905268) (← links)
- Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen (Q35948773) (← links)
- Impact of immunohistochemistry-based molecular subtype on chemosensitivity and survival in patients with breast cancer following neoadjuvant chemotherapy (Q36092031) (← links)
- Phase II trial of neoadjuvant exemestane in combination with celecoxib in postmenopausal women who have breast cancer. (Q36230831) (← links)
- Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancer (Q36287107) (← links)
- Peripheral neuropathies from chemotherapeutics and targeted agents: diagnosis, treatment, and prevention (Q36344699) (← links)
- Primary Hormone Therapy in Elderly Women with Hormone-Sensitive Locoregional Breast Cancer: Endocrine Therapy Alone Is a Reasonable Alternative in Selected Patients (Q36350006) (← links)
- Systemic treatment in breast cancer: a primer for radiologists (Q36510679) (← links)
- Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas (Q36594068) (← links)
- Network Meta-Analysis of the Effectiveness of Neoadjuvant Endocrine Therapy for Postmenopausal, HR-Positive Breast Cancer (Q36897982) (← links)
- Advances in the treatment of breast cancer (Q37037373) (← links)
- Letrozole Potentiates Mitochondrial and Dendritic Spine Impairments Induced by β Amyloid (Q37061881) (← links)
- Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial (Q37135224) (← links)
- Alopecia with endocrine therapies in patients with cancer. (Q37247197) (← links)
- Diagnosis and medical treatment of breast cancer. Cordoba Consensus of 2007. (Q37270931) (← links)
- Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries (Q37287552) (← links)
- Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women (Q37366511) (← links)
- The aryl hydrocarbon receptor as a target for estrogen receptor-negative breast cancer chemotherapy (Q37397536) (← links)
- Neoadjuvant Hormonal Therapy is Associated with Comparable Outcomes to Neoadjuvant Chemotherapy in Post-Menopausal Women with Estrogen Receptor-Positive Breast Cancer (Q37415526) (← links)
- Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again? (Q37577665) (← links)
- Modern Approach to Metabolic Rehabilitation of Cancer Patients: Biguanides (Phenformin and Metformin) and Beyond (Q37783621) (← links)
- What's new in neoadjuvant therapy for breast cancer? (Q37797337) (← links)
- Neoadjuvant endocrine therapy of breast cancer: which patients would benefit and what are the advantages? (Q37812012) (← links)
- Neoadjuvant endocrine therapy for postmenopausal patients with hormone receptor-positive early breast cancer: a new concept (Q37817838) (← links)
- Pathologic tumor response of invasive lobular carcinoma to neo-adjuvant chemotherapy (Q38049191) (← links)
- Breast cancer management in the elderly (Q38148495) (← links)
- Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer (Q38157648) (← links)
- Management of locally advanced breast cancer-perspectives and future directions (Q38350939) (← links)
- Impact of Chemotherapy-Induced Ovarian Dysfunction on Response to Neoadjuvant Chemotherapy in Breast Cancer (Q38423323) (← links)
- Analysis of Ki-67 expression with neoadjuvant anastrozole or tamoxifen in patients receiving goserelin for premenopausal breast cancer. (Q38464311) (← links)
- Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis. (Q38658509) (← links)
- Recent Advances in the Neoadjuvant Treatment of Breast Cancer (Q38687392) (← links)
- Implementing neoadjuvant endocrine strategies in ER-positive, HER2-negative breast cancer (Q38765017) (← links)
- Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer: A Systematic Review and Meta-analysis. (Q38883281) (← links)
- Short-term outcomes of neoadjuvant hormonal therapy versus neoadjuvant chemotherapy in breast cancer: systematic review and meta-analysis of randomized controlled trials (Q39167766) (← links)